Home / PKIB Knockout Cell Lines

PKIB Knockout Cell Lines

Gene: PKIB

Official Full Name: cAMP-dependent protein kinase inhibitor betaprovided by HGNC

Gene Summary: This gene encodes a member of the cAMP-dependent protein kinase inhibitor family. The encoded protein may play a role in the protein kinase A (PKA) pathway by interacting with the catalytic subunit of PKA, and overexpression of this gene may play a role in prostate cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO35925 PKIB Knockout cell line (HeLa) Human PKIB 1:3~1:6 Negative Online Inquiry
KO35926 PKIB Knockout cell line (HCT 116) Human PKIB 1:2~1:4 Negative Online Inquiry
KO35927 PKIB Knockout cell line (HEK293) Human PKIB 1:3~1:6 Negative Online Inquiry

Background

PKIB Gene Knockout Cell Lines are advanced biological tools designed for gene function analysis and therapeutic development. These genetically modified cell lines exhibit complete disruption of the PKIB (Protein Kinase Inhibitor Beta) gene, facilitating insights into cellular signaling pathways that govern critical biological processes, such as cell proliferation, metabolism, and apoptosis. By removing the functional capacity of PKIB, researchers can effectively study its role in various disease contexts, including cancer and metabolic disorders.

The principal mechanism by which PKIB Gene Knockout Cell Lines operate hinges on the targeted deletion of the PKIB gene using CRISPR-Cas9 technology, a precision editing tool that allows for specific genomic alterations. This method ensures a robust and reproducible model that mimics the physiological conditions often observed in vivo, thereby enhancing the reliability of experimental outcomes.

The scientific importance of these knockout cell lines cannot be overstated, as they enable researchers to dissect complex signaling networks and uncover new therapeutic targets. In clinical settings, understanding the role of PKIB in tumor growth and drug resistance can drive the development of innovative treatment strategies. These cell lines are particularly beneficial in pharmacological studies, where the evaluation of novel inhibitors can be directly correlated with PKIB modulation.

Comparatively, PKIB Gene Knockout Cell Lines offer distinct advantages over traditional knockdown models, such as siRNA or shRNA, which may lead to partial or transient gene silencing. Our knockout models provide a stable and permanent solution for long-term studies, thereby ensuring more consistent results. Furthermore, the ability to generate these lines with high efficiency allows for quicker turnaround times in experimental design.

For researchers and clinicians, the value of PKIB Gene Knockout Cell Lines lies in their ability to unlock new avenues of understanding disease mechanisms, potentially contributing to groundbreaking therapies. By employing these advanced cell models, users can accelerate their research objectives while enhancing the reproducibility of their findings.

Our company prides itself on our expertise in providing high-quality genetic tools designed to empower the scientific community. With a commitment to innovation and excellence, we offer a comprehensive range of biological products that meet the evolving needs of researchers and clinicians worldwide.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.